Company: ACBM
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001640334-25-001999
Chunk: 2

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 1
Chunk 2
---
301)  (10,301)                             Balance, March 31, 2025  -   -   60,042,000   60,042   32,304,148   (32,668,096)  (303,906)                             Imputed interest on related party loans  -   -   -   -   1,948   -   1,948 Net loss  -   -   -   -   -   (15,562)  (15,562)                             Balance, June 30, 2025  -   -   60,042,000   60,042   32,306,096   (32,683,658)  (317,520)                             Imputed interest on related party loans  -   -   -   -   2,710   -   2,710 Net loss  -   -   -   -   -   (117,809)  (117,809)                             Balance, September 30, 2025  -  $-   60,042,000  $60,042  $32,308,806  $(32,801,467) $(432,619)

For the Three and Nine months ended September 30, 2024

              Additional     Total   Preferred Stock  Common Stock   Paid in   Accumulated  Stockholders’     Shares    Amount    Shares    Amount    Capital    Deficit   Deficit                       Balance, December 31, 2023  -  $-   60,042,000  $60,042  $32,298,442  $(32,615,498) $(257,014)                             Imputed interest on related party loans  -   -   -   -   954   -   954 Net loss  -   -   -   -   -   (11,252)  (11,252)